Growth failure and outcome in Rett syndrome: specific growth references

Daniel Charles Tarquinio1, Kathleen J Motil, Wei Hou

  • 1Miami Children's Hospital, Miami, FL, USA. danieltarq@aol.com

Neurology
|October 5, 2012
PubMed

Insights

Growth charts for Rett syndrome (RTT) reveal significant growth failure in affected children compared to the general population. Specific MECP2 mutations and disease severity correlate with poorer growth outcomes in RTT patients.

Area of Science:

  • Pediatrics
  • Genetics
  • Clinical Research

Background:

  • Rett syndrome (RTT) is characterized by significant growth failure.
  • Developing RTT-specific growth references is crucial for clinical management and research.
  • Understanding growth patterns across different RTT genotypes and phenotypes is essential.

Purpose of the Study:

  • To create RTT-specific growth charts for height, weight, head circumference, and BMI.
  • To compare growth trajectories of children with RTT against unaffected children.
  • To analyze growth variations based on RTT genotypes and phenotypes.

Main Methods:

  • Utilized a cohort from the RTT Rare Diseases Clinical Research Network observational study.
  • Collected cross-sectional and longitudinal growth data and clinical information.
  • Generated reference curves using a semiparametric model and compared them to normative values; analyzed genotype/phenotype subgroups with ANOVA and regression.

Main Results:

  • Created growth charts from 9,749 observations of 816 female participants with classic and atypical RTT.
  • Classic RTT exhibited growth failure starting early in infancy (head circumference at 1 month, weight at 6 months, length at 17 months).
  • Absence of pubertal growth spurts and association of poor growth with worse development, higher disease severity, and specific MECP2 mutations were noted.

Conclusions:

  • RTT-specific growth references facilitate early disease screening and treatment monitoring.
  • Growth failure is less common in RTT patients with better development, lower morbidity, and specific late-truncation MECP2 mutations.
Abstract

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...